Results of a systematic review and meta-analysis showed that LDN was safe and effective for reducing pain and improving functional outcomes in fibromyalgia.

ZTlido ® is a registered trademark owned by Scilex Pharmaceuticals Inc., a wholly-owned subsidiary of Scilex Holding Company. Gloperba ® is the subject of an exclusive, transferable license to use the ...

Scilex’s shareholders as of the record date of November 14, 2025 will receive one meme coin for each common share held. This digital collectible is intended to provide for immutable recognition of ...

Datavault AI Inc. Announces a $10M Worldwide Exclusive License Agreement with Scilex Holding Company for Tokenization and Monetization of Real-World Assets (RWA) in Genomic, DNA Data, Diagnostics, ...

Currax Pharmaceuticals LLC ("Currax"), a pharmaceutical company that delivers life-changing medicines to patients with chronic, progressive diseases, today announced that leading obesity experts will ...

After years of symptoms and misdiagnoses, one patient shares how he learned he had a life-altering condition that challenges ...

Indivior PLC  presented three new scientific posters at the Academy of Managed Care Pharmacy (AMCP) Nexus 2025 conference last week, showcasing real-world evidence on the clinical and economic impact ...

Untreated chronic pain patients on waitlists for psychological care show no significant symptom change over short periods, according to a recent meta-analysis.

Current smoking was the most important predictor for a detrimental effect of aspirin on cancer incidence, whereas CHIP was the most important predictor for a beneficial effect of aspirin,” researchers ...